Ray Dalio
CVAC

Ray Dalio’s CureVac CVAC Stock Holding History

Ray Dalio’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-466,407
Closed -$2.51M – 1086
2025
Q3 		$2.51M Buy
+466,407
New +$2.52M 0.01% 673

Other funds holding CVAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Ray Dalio's CVAC Position: Q4 2025 in Review

Ray Dalio sold out of CureVac (CVAC) in Q4 2025, closing a stake of 466,407 shares — an estimated $2.51M sold.

Ray Dalio first reported a position in CVAC in Q3 2025 and held it in 1 quarter. The position peaked at $2.51M in Q3 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Ray Dalio reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Ray Dalio sold 466,407 CureVac shares in Q4 2025, an estimated $2.51M.
  • Ray Dalio first reported a position in CureVac in Q3 2025 and held it in 1 quarter.
  • Ray Dalio's CureVac position peaked at $2.51M in Q3 2025.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Bridgewater Associates's 13F filing for Q4 2025, filed 13 Feb 2026.